On September 11, 2018, hospital advocacy groups and three individual hospitals filed a complaint in the United States District Court for the District of Columbia.
The National Labor Relations Board (NLRB or Board) published a Notice of Proposed Rulemaking in the Federal Register on September 14, 2018 regarding its controversial joint-employer standard.
Schiff Hardin LLP is pleased to announce that 11 attorneys have been recognized on the 2018 New York Metro Super Lawyers list and two have been named Rising Stars.
In this video episode of Fashion Counsel, Arent Fox Partner Anthony Lupo and Social Media Influencer Jeremy Fragrance discuss industry trends and branding.
For the second straight year, Schiff Hardin LLP has ranked among the top large law firms in Chicago and nationwide for associate satisfaction, according to the results of the 2018 Midlevel Associate Satisfaction survey by The American Lawyer.
Schiff Hardin LLP is proud to announce its support of an innovative pledge campaign by the American Bar Association (ABA) aimed at targeting substance use disorders and mental health issues among lawyers.
Schiff Hardin LLP announced today that Derek G. Barella has joined the firm as a partner in the Labor and Employment Practice Group in the Chicago office.
Health care plans are seeing an increase in the number of claims from their enrollees for reimbursement for mental health, behavioral, and substance abuse services obtained at “wilderness camps.”
Schiff Hardin LLP is pleased to announce that the firm has been recognized by the Construction Lawyers Society of America (CLSA) with a 2018 CLSA Law Firm Award in recognition of its excellence in construction law.
Schiff Hardin LLP has been singled out by corporate counsel as one of only 28 percent of law firms clients view as a BTI “Innovation Builder,” which recognizes firms that bring change to the legal market through new technology, services, strategies, or structures.
On August 28, 2018, the United States District Court for the Eastern District of California (the Court) dismissed with leave to amend the Pharmaceutical Research and Manufacturers of America’s (PhRMA) lawsuit challenging the constitutionality of California’s new drug price transparency law.
In a recent decision, the Sixth Circuit adopted an objective intent standard: an employee alleging constructive discharge in violation of the False Claims Act need not prove that the employer took actions designed to force the employee to quit.
Intellectual Property Group Co-Leader Imron Aly represented Alkem Laboratories Ltd. as part of a group of generic drug makers urging a Federal Circuit panel to nix patents for the tapentadol opioid painkiller Nucynta, marketed by Depomed (now Assertio). IP Law360 reported on the oral argument.